Hubei Jumpcan Pharmaceutical Co., LtdSSE: 600566

(600566)"Hubei Jumpcan Pharmaceutical Co., Ltd."Report for Q3 2026

Oct 30, 2026 · Issued by Hubei Jumpcan Pharmaceutical Co., Ltd via Shanghai Stock Exchange

Filed with SSE · Stock code 600566 · Oct 30, 2026

On 6ix: 6ix.com/news/600566hubei-jumpcan-pharmaceutical-co-ltdreport-for-q3-2026

Report for Q3 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix is reading this filing.

View original source (Shanghai Stock Exchange)Hubei Jumpcan Pharmaceutical Co., Ltd on 6ix

Earlier from Hubei Jumpcan Pharmaceutical

(600566)"Hubei Jumpcan Pharmaceutical Co., Ltd."Announcement on Results of Shareholding Reduction by Certain Senior ExecutivesOct 15
(600566)"Hubei Jumpcan Pharmaceutical Co., Ltd."Indicative Announcement on Restricted Exercise Period for the Initial Grant of Stock Options under the 2022 Restricted Share and Stock Option Incentive PlanOct 9
(600566)"Hubei Jumpcan Pharmaceutical Co., Ltd."Announcement on Self-exercise Results in Q3 2026 under the 2022 Restricted Share and Stock Option Incentive Plan and Changes in Share CapitalOct 9
(600566)"Hubei Jumpcan Pharmaceutical Co., Ltd."Announcement on Progress in Repurchasing Shares through Call AuctionOct 9
(600566)"Hubei Jumpcan Pharmaceutical Co., Ltd."Announcement on Convening the 2026 Semi-annual Performance BriefingOct 9

All Hubei Jumpcan Pharmaceutical news releases

Follow Hubei Jumpcan Pharmaceutical into a list and get an email when it puts out news.

Follow Hubei Jumpcan Pharmaceutical